Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

GSK plc announced plans to invest $30 billion in U.S. research and manufacturing over the next five years and entered a $500 ...

The latest update is out from GlaxoSmithKline ( (GB:GSK) ).

NICE recommends ViiV Healthcare's Apretude as the first injectable PrEP for HIV prevention, offering an alternative to daily ...

GSK plc has announced the purchase of 310,000 of its own ordinary shares as part of its ongoing buyback program. This transaction, executed through BNP Paribas SA, is part of a broader strategy to ...

Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best stocks to buy according to Jim Simons’ Renaissance Technologies. On ...

CEO Emma Walmsley said GSK has had a minimal role in an effort by the FDA to update the prescribing information of the ...

If you are on the fence about what to do with your GSK shares, you are not alone. The stock has seen some interesting moves ...

Lloyds Banking Group today made a big increase to the amount it will need to cover motor finance mis-selling compensation.

Novo Nordisk saw a competitor’s bet and raised the stakes in metabolic dysfunction-associated steatohepatitis (MASH) with its planned up-to-$5.2 billion acquisition of Akero Therapeutics.

Gains are being driven in particular by the financial sector, as well as the FTSE’s defensive qualities and income-generating ...

Unlike peers, GSK plc faces limited Loss of Exclusivity risk, supporting steady revenue projections and justifying higher ...